Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-25-005861

Chief Accounting Officer acquired 41,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kallebo Lisa Michelle Chief Accounting Officer 2025-02-13 Grant or award +41,900 $1.61 $67,459 77,897 D
Loading xslF345X05/wk-form4_1739575330.xml…